Back
Matthews Emerging Markets Ex Chn Act ETF Vs. Nutex Health Industry Stock Comparison
Buy
57
MEMX
Matthews Emerging Markets Ex Chn Act ETF
Last Price:
29.47
Seasonality Move:
8.21%
Buy
58
NUTX
Nutex Health
Last Price:
32.38
Seasonality Move:
-16.36%
Buy
57
Matthews Emerging Markets Ex Chn Act ETF (MEMX)
is a Buy
Is Matthews Emerging Markets Ex Chn Act ETF a Buy, Sell or Hold?
- The current Matthews Emerging Markets Ex Chn Act ETF [MEMX] share price is $29.50. The Score for MEMX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- MEMX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Nutex Health (NUTX)
is a Buy
Is Nutex Health a Buy, Sell or Hold?
- The current Nutex Health [NUTX] share price is $32.62. The Score for NUTX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- NUTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MEMX Stock Price Chart
What is Matthews Emerging Markets Ex Chn Act ETF's stock price today?
-
The Matthews Emerging Markets Ex Chn Act ETF share price today is $29.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MEMX is experiencing selling pressure, which indicates risk of future bearish movement.
NUTX Stock Price Chart
What is Nutex Health's stock price today?
-
The Nutex Health share price today is $32.62
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUTX is experiencing selling pressure, which indicates risk of future bearish movement.
MEMX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 31.63 | Sell |
| Chaikin Money Flow: | -2451 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.07 - 30.77) | Sell |
| Bollinger Bands (100): | (29.8 - 30.98) | Sell |
NUTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.83 | Buy |
| Relative Strength Index (14 RSI): | 62.26 | Buy |
| Chaikin Money Flow: | -85516 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20 - 28.76) | Buy |
| Bollinger Bands (100): | (8.72 - 24.98) | Buy |
MEMX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.08 | Sell |
| 20-day SMA: | 30.37 | Sell |
| 50-day SMA: | 30.52 | Sell |
| 200-day SMA: | 29.62 | Sell |
| 8-day EMA: | 29.98 | Sell |
| 20-day EMA: | 30.25 | Sell |
| 50-day EMA: | 30.38 | Sell |
| 200-day EMA: | 29.51 | Sell |
NUTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.14 | Buy |
| 20-day SMA: | 25.59 | Buy |
| 50-day SMA: | 23.17 | Buy |
| 200-day SMA: | 14.02 | Buy |
| 8-day EMA: | 29.96 | Buy |
| 20-day EMA: | 26.54 | Buy |
| 50-day EMA: | 22.9 | Buy |
| 200-day EMA: | 24.52 | Buy |
Matthews Emerging Markets Ex Chn Act ETF Earnings Growth & MEMX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nutex Health Earnings Growth & NUTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $1.74 per share.
Matthews Emerging Markets Ex Chn Act ETF Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nutex Health Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||